Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
drugs
5
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
pfizer
5
×
san diego blog main
san diego top stories
5
×
clinical trials
abbvie
biotech
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
akcea therapeutics
astrazeneca
bristol-myers squibb
cancer immunotherapy
celgene
eli lilly
inotersen
What
drug
fda
alnylam
annual
approved
bio
conference
disease
europe
roundup
ago
akcea
alzheimer’s
american
amyloidosis
approves
ash
assessed
attention
attr
available
battle
biotech
blood
borne
cancers
cells
communities
companies
debilitating
diego
digital
ema
employ
epidemic
esmo
fatty
follows
frenzied
gathering
Language
Current search:
pfizer
×
drugs
×
" san diego top stories "
×
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug